Latest Pneumococcal conjugate vaccine Stories
Using a cross-sectional study, Stefan Flasche and colleagues investigated the effects of the UK pneumococcal vaccination program on serotype-specific carriage and invasive pneumococcal disease.
BEIJING, March 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Two widely-used vaccines made by Pfizer and Sanofi-Aventis have been suspended for use in Japan, as the health ministry investigates whether they are linked to the recent deaths of four infants.
BEIJING, March 3, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia.
Pneumococcus (Streptococcus pneumoniae) accounts for as much as 11 percent of mortality in young children worldwide.
Experts say that children will be better protected against pneumonia and other infections caused by the pneumococcus bacterium with this year's updated immunization schedule.
BEIJING, Jan. 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
NEW YORK, Dec.
NEW YORK, Dec. 12, 2010 /PRNewswire/ -- Pfizer Inc.
- A woman chauffeur.
- A woman who operates an automobile.